|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/445 | (2006.01) |
| A61K 31/522 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 4385509 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23176366.5 |
| Date of filing the European patent application | 2023-05-31 | |
| (97) | Date of publication of the European application | 2024-06-19 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-03 |
| (46) | Date of publication of the claims translation | 2025-12-29 |
| (30) | Number | Date | Country code |
| 202263432235 P | 2022-12-13 | US | |
| 202318315928 | 2023-05-11 | US |
| (72) |
JOHNSON, Franklin , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Migalastato dozavimo režimas, pasižymintis pagerinta farmakokinetika |
| MIGALASTAT DOSAGE REGIMEN HAVING IMPROVED PHARMACOKINETICS |